Archive

Dive into a collection of past posts.

⚡New long acting IL13 antibody for eczema

Jul 12, 2025

⚡New long acting IL13 antibody for eczema

⚡First-in-class Treg therapy for eczema

Jul 5, 2025

⚡First-in-class Treg therapy for eczema

⚡First FDA-approved biologic for BP

Jun 28, 2025

⚡First FDA-approved biologic for BP

⚡Anti-KIT in CSU, povorcitinib for vitiligo, and guselkumab in PsA

Jun 21, 2025

⚡Anti-KIT in CSU, povorcitinib for vitiligo, and guselkumab in PsA

⚡First oral FASN inhibitor for acne

Jun 14, 2025

⚡First oral FASN inhibitor for acne

⚡Two firsts in SCC, landmark Botox trial, and ucenprubart for AD

Jun 7, 2025

⚡Two firsts in SCC, landmark Botox trial, and ucenprubart for AD

⚡Opzelura in pediatric AD, AI melanoma launch, and Cabtreo vs Epiduo Forte

May 31, 2025

⚡Opzelura in pediatric AD, AI melanoma launch, and Cabtreo vs Epiduo Forte

⚡First ITK blocker in atopic dermatitis

May 24, 2025

⚡First ITK blocker in atopic dermatitis

⚡Zoryve for psoriasis, BTK inhibitors miss, and keloid protocol with durable results

May 10, 2025

⚡Zoryve for psoriasis, BTK inhibitors miss, and keloid protocol with durable results

⚡First single-treatment EB gene therapy approved

May 3, 2025

⚡First single-treatment EB gene therapy approved